Cytomegalovirus (CMV) retinitis can be a devastating infection in patients with HIV disease. Prophylaxis can be effective in preventing disease in susceptible patients. Patients receiving highly active antiretroviral therapy (HAART) may be able to stop prophylaxis if certain criteria are met.